Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GLP1R | P43220 | 8/20 | 0.72 |
| ▸ | GCGR | P47871 | 3/20 | 0.72 |
| ▸ | NPY2R | P49146 | 2/20 | 0.71 |
| ▸ | NPY4R | P50391 | 2/20 | 0.71 |
| ▸ | NPY5R | Q15761 | 2/20 | 0.71 |
| ▸ | NPY1R | P25929 | 1/20 | 0.71 |
| ▸ | CCKBR | P32239 | 4/20 | 0.70 |
| ▸ | CXCR4 | P61073 | 3/20 | 0.69 |
| ▸ | CALCR | P30988 | 4/20 | 0.66 |
| ▸ | C5AR1 | P21730 | 1/20 | 0.66 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30527854 | 1.00 | GLP1R (0.72) | GLP1RGCGRNPY2RNPY4RNPY5R | |
| SCHEMBL30527942 | 0.96 | NPY2R (0.75) | GLP1RGCGRNPY2RNPY4RNPY5R | |
| SCHEMBL30692431 | 0.96 | NPY2R (0.75) | GLP1RGCGRNPY2RNPY4RNPY5R | |
| SCHEMBL29416049 | 0.96 | NPY2R (0.75) | GLP1RGCGRNPY2RNPY4RNPY5R | |
| SCHEMBL29416107 | 0.94 | GLP1R (0.69) | GLP1RGCGRNPY2RNPY4RNPY5R | |
| SCHEMBL30692441 | 0.93 | GLP1R (0.69) | GLP1RGCGRNPY2RNPY4RNPY5R | |
| SCHEMBL30530323 | 0.93 | GLP1R (0.69) | GLP1RGCGRNPY2RNPY4RNPY5R | |
| SCHEMBL29706316 | 0.92 | GLP1R (0.71) | GLP1RGCGRNPY2RNPY4RNPY5R | |
| SCHEMBL31027131 | 0.92 | CALCR (0.76) | GLP1RGCGRNPY2RNPY4RNPY5R | |
| SCHEMBL29638067 | 0.92 | GLP1R (0.74) | GLP1RGCGRNPY2RNPY4RNPY5R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114099636-A | Method of treating a condition requiring cell destruction or removal using peptides derived from neurofilament proteins | 尼莫克斯制药公司 | 2022-03-01 | — | — | CN | disclosed |